Altamira Therapeutics Ltd (CYTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2004 | 03-2004 | 12-2003 | 09-2003 | 06-2003 | |
| Gross Profit | 1,550 | 1,200 | 1,240 | 3,350 | 1,420 |
| Operating Expenses | 540 | 940 | 150 | 900 | 770 |
| Operating Income | -540 | -940 | -150 | -900 | -770 |
| Pre-tax Income | -540 | -940 | -150 | -900 | -770 |
| Net Income Continuous | -540 | -940 | -150 | -900 | -770 |
| Net Income | $-540 | $-940 | $-150 | $-900 | $-770 |
| EBITDA(a) | $-270 | $-680 | $100 | $-2,810 | $-530 |